SF-3-030

N/A

Report date: 2025/01/26 17:51:37

NME

Base Information

Drug NameSF-3-030

Drug Alias Namefunction-selective type IV ERK2 inhibitor (Thomas Jefferson University/University of Maryland)substrate selective ERK1/2 inhibitor (Thomas Jefferson University/University of Maryland)SF-3-030

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionExtracellular-signal-regulated kinase 2 inhibitors

TargetsExtracellular-signal-regulated kinase 2

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThomas Jefferson University

China Registration ClassN/A

Develop Information

Active CompaniesThomas Jefferson University University Of Maryland

Inactive CompaniesN/A

Active IndicationsAsthma

Inactive IndicationsN/A

Other Information

ATC CodeN/A